pyrroles has been researched along with naproxen in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (36.00) | 18.7374 |
| 1990's | 1 (4.00) | 18.2507 |
| 2000's | 7 (28.00) | 29.6817 |
| 2010's | 8 (32.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boyle, E; Freeman, PC; Goudie, AC; Mangan, FR; Thomson, M | 1 |
| Lewis, JR | 1 |
| Scherbel, AL | 1 |
| Zarro, VJ | 1 |
| Vetter, G | 1 |
| Barden, TP; Bloomfield, SS; Cissell, GB; Mitchell, J; Nelson, ED; Peters, NM | 1 |
| Caldwell, JR; Crain, D; Hoffmeister, RT; Kantrowitz, F; Lloyd, RJ; Nussdorf, RT; Repice, MR; Schmid, FR | 1 |
| Famaey, JP; Ginsberg, F | 1 |
| Bach-Andersen, R; Persson, B; Telhag, H | 1 |
| Antoon, JS; Perry, MA; Walker, JS; Wilson, JL | 1 |
| Celotti, F; Durand, T | 1 |
| Bias, P; Buchner, A; Klesser, B; Laufer, S | 1 |
| Guévremont, M; Laufer, S; Marcouiller, P; Martel-Pelletier, J; Pelletier, JP; Ranger, P; Reboul, P | 1 |
| Breese, T; Dale, JC; Harris, SI; Lawson, J; McLaughlin, P; Moberly, JB; Riff, DS; Truitt, KE; Wan, Y; Xu, J | 1 |
| Abram, F; Beaulieu, AD; Bias, P; Choquette, D; Dorais, M; Haraoui, B; Laufer, S; Martel-Pelletier, J; Pelletier, JP; Raynauld, JP; Vignon, E | 1 |
| Ferringer, T; Lountzis, NI; Puri, PK; Tyler, W | 1 |
| Abram, F; Bias, P; Choquette, D; Dorais, M; Emmert, KH; Haraoui, B; Laufer, S; Martel-Pelletier, J; Pelletier, JP; Raynauld, JP | 1 |
| Abram, F; Caron, J; Choquette, D; Dorais, M; Haraoui, B; Martel-Pelletier, J; Mineau, F; Pelletier, JP; Raynauld, JP | 1 |
| Abram, F; Dorais, M; Martel-Pelletier, J; Pelletier, JP; Raynauld, JP; Wildi, LM | 1 |
| Abram, F; Choquette, D; Dorais, M; Haraoui, B; Martel-Pelletier, J; Pelletier, JP; Raynauld, JP; Wildi, LM | 1 |
| DeCastro, A; Janakiram, NB; Lee, HJ; Paul, S; Rao, CV; Reddy, BS; Simi, B; Smolarek, AK; So, JY; Steele, V; Suh, N; Wang, CX | 1 |
| Bagheri, H; Baktash, MY; Roostaie, A | 1 |
| Ahmadi, SH; Heydar, KT; Manbohi, A | 1 |
| Anzini, M; Belmonte, G; Biava, M; Cheleschi, S; Di Capua, A; Fioravanti, A; Giordani, A; Pascarelli, NA; Sticozzi, C; Valacchi, G | 1 |
| Liu, M; Martel-Pelletier, J; Pelletier, JP; Rahman, P; Randell, EW; Zhai, G | 1 |
1 review(s) available for pyrroles and naproxen
| Article | Year |
|---|---|
The metabolic effects of inhibitors of 5-lipoxygenase and of cyclooxygenase 1 and 2 are an advancement in the efficacy and safety of anti-inflammatory therapy.
Topics: Acetates; Anti-Inflammatory Agents, Non-Steroidal; Arachidonate 5-Lipoxygenase; Cardiovascular System; Clinical Trials, Phase III as Topic; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Intestinal Mucosa; Isoenzymes; Leukotrienes; Lipoxygenase Inhibitors; Membrane Proteins; Naproxen; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Pyrroles | 2003 |
12 trial(s) available for pyrroles and naproxen
| Article | Year |
|---|---|
Double-blind cross-over study of clopirac and naproxen in rheumatoid arthritis.
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Humans; Naphthaleneacetic Acids; Naproxen; Pyrroles | 1975 |
Anirolac vs. naproxen for postpartum uterine pain.
Topics: Administration, Oral; Adolescent; Adult; Double-Blind Method; Drug Evaluation; Female; Humans; Naproxen; Pain; Postpartum Period; Pregnancy; Pyrroles; Random Allocation | 1987 |
Four-way, multicenter, crossover trial of ibuprofen, fenoprofen calcium, naproxen, and tolmetin sodium in osteoarthritis: comparative clinical profiles.
Topics: Adult; Aged; Aspirin; Clinical Trials as Topic; Double-Blind Method; Drug Tolerance; Female; Fenoprofen; Humans; Ibuprofen; Male; Middle Aged; Naproxen; Osteoarthritis; Phenylpropionates; Pyrroles; Tolmetin | 1983 |
A double-blind comparative evaluation of tolmetin versus naproxen in osteoarthritis.
Topics: Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Naproxen; Osteoarthritis; Pain; Pyrroles; Tolmetin | 1981 |
The gastrointestinal tolerability of the LOX/COX inhibitor, licofelone, is similar to placebo and superior to naproxen therapy in healthy volunteers: results from a randomized, controlled trial.
Topics: Acetates; Adult; Cyclooxygenase Inhibitors; Duodenoscopy; Duodenum; Female; Gastric Mucosa; Gastroscopy; Humans; Incidence; Intestinal Mucosa; Lipoxygenase Inhibitors; Male; Naproxen; Peptic Ulcer; Pyrroles | 2004 |
A randomized, double-blind, one-week study comparing effects of a novel COX-2 inhibitor and naproxen on the gastric mucosa.
Topics: Adult; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Duodenal Ulcer; Duodenum; Endoscopy, Gastrointestinal; Female; Gastric Mucosa; Humans; Intestinal Mucosa; Male; Membrane Proteins; Middle Aged; Naproxen; Pyrroles; Reference Values; Stomach Ulcer; Sulfonamides; Time Factors; United States | 2007 |
Protective effects of licofelone, a 5-lipoxygenase and cyclo-oxygenase inhibitor, versus naproxen on cartilage loss in knee osteoarthritis: a first multicentre clinical trial using quantitative MRI.
Topics: Aged; Antirheumatic Agents; Cartilage, Articular; Chi-Square Distribution; Cyclooxygenase Inhibitors; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Knee Joint; Lipoxygenase Inhibitors; Magnetic Resonance Imaging; Male; Middle Aged; Naproxen; Osteoarthritis, Knee; Pain Measurement; Pyrroles; Radiography; Treatment Outcome | 2009 |
Analysis of the precision and sensitivity to change of different approaches to assess cartilage loss by quantitative MRI in a longitudinal multicentre clinical trial in patients with knee osteoarthritis.
Topics: Cartilage, Articular; Double-Blind Method; Female; Follow-Up Studies; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Naproxen; Osteoarthritis, Knee; Pyrroles; Sensitivity and Specificity | 2008 |
Decrease in serum level of matrix metalloproteinases is predictive of the disease-modifying effect of osteoarthritis drugs assessed by quantitative MRI in patients with knee osteoarthritis.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; C-Reactive Protein; Cartilage, Articular; Drug Monitoring; Female; Humans; Magnetic Resonance Imaging; Male; Matrix Metalloproteinases; Middle Aged; Naproxen; Osteoarthritis, Knee; Pyrroles; Severity of Illness Index; Treatment Outcome | 2010 |
Relationship between bone marrow lesions, cartilage loss and pain in knee osteoarthritis: results from a randomised controlled clinical trial using MRI.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Bone Marrow Diseases; Cartilage, Articular; Cyclooxygenase Inhibitors; Epidemiologic Methods; Female; Humans; Knee Joint; Magnetic Resonance Imaging; Male; Middle Aged; Naproxen; Osteoarthritis, Knee; Pain; Pain Measurement; Pyrroles | 2010 |
Risk factors predictive of joint replacement in a 2-year multicentre clinical trial in knee osteoarthritis using MRI: results from over 6 years of observation.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthroplasty, Replacement, Knee; C-Reactive Protein; Disease Progression; Epidemiologic Methods; Female; Humans; Knee Joint; Magnetic Resonance Imaging; Male; Menisci, Tibial; Middle Aged; Naproxen; Osteoarthritis, Knee; Prognosis; Pyrroles; Tibial Meniscus Injuries | 2011 |
Serum lysophosphatidylcholines to phosphatidylcholines ratio is associated with symptomatic responders to symptomatic drugs in knee osteoarthritis patients.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Cyclooxygenase Inhibitors; Female; Humans; Lysophosphatidylcholines; Male; Middle Aged; Naproxen; Osteoarthritis, Knee; Phosphatidylcholines; Pyrroles; Treatment Outcome | 2019 |
12 other study(ies) available for pyrroles and naproxen
| Article | Year |
|---|---|
The role of copper in preventing gastrointestinal damage by acidic anti-inflammatory drugs.
Topics: Acetates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chelating Agents; Copper; Edema; Female; In Vitro Techniques; Indomethacin; Ketoprofen; Male; Naproxen; Niflumic Acid; Peptic Ulcer; Prostaglandins E; Pyrroles; Rats | 1976 |
New antirheumatic agents: Fenoprofen calcium (Nalfon), naproxen (Naprosyn), and tolmetin sodium (Tolectin).
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Aspirin; Fenoprofen; Gastrointestinal Hemorrhage; Humans; Naphthaleneacetic Acids; Naproxen; Osteoarthritis; Phenylpropionates; Pyrroles; Rheumatic Diseases; Spondylitis, Ankylosing; Tolmetin | 1977 |
Nonsteroidal antiinflammatory drugs: new alternatives for rheumatic disease.
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Fenoprofen; Humans; Ibuprofen; Naproxen; Phenylpropionates; Pyrroles; Tolmetin | 1978 |
New nonsteroidal anti-inflammatory drugs.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Aspirin; Fenoprofen; Humans; Ibuprofen; Naphthaleneacetic Acids; Naproxen; Phenylpropionates; Pyrroles; Tolmetin | 1976 |
[Double-blind study of tolmetin osteoarthritis (author's transl)].
Topics: Adult; Aged; Back Pain; Double-Blind Method; Humans; Middle Aged; Naproxen; Osteoarthritis; Pyrroles; Spinal Diseases; Tolmetin | 1980 |
Intercellular adhesion molecule-1 expression in adjuvant arthritis in rats: inhibition by kappa-opioid agonist but not by NSAID.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Female; Intercellular Adhesion Molecule-1; Naproxen; Narcotics; Pyrroles; Rats; Rats, Inbred Lew; Receptors, Opioid, kappa; Thiophenes | 1998 |
Leukotriene and prostaglandin synthesis pathways in osteoarthritic synovial membranes: regulating factors for interleukin 1beta synthesis.
Topics: Acetates; Aged; Arachidonic Acid; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; In Vitro Techniques; Leukotriene B4; Lipopolysaccharides; Male; Masoprocol; Naproxen; Osteoarthritis, Knee; Pyrroles; Signal Transduction; Synovial Membrane | 2005 |
Hydroxychloroquine-induced hyperpigmentation: the staining pattern.
Topics: Aged; Antacids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Aspirin; Atorvastatin; Calcium Carbonate; Cardiomyopathy, Restrictive; Citalopram; Connective Tissue Diseases; Diuretics; Female; Furosemide; Glucosamine; Heptanoic Acids; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperpigmentation; Lupus Erythematosus, Systemic; Magnesium; Metolazone; Middle Aged; Naproxen; Omeprazole; Potassium Chloride; Prednisone; Pyrroles; Selective Serotonin Reuptake Inhibitors; Spironolactone | 2008 |
Combination of atorvastatin with sulindac or naproxen profoundly inhibits colonic adenocarcinomas by suppressing the p65/β-catenin/cyclin D1 signaling pathway in rats.
Topics: Adenocarcinoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Antineoplastic Combined Chemotherapy Protocols; Atorvastatin; Azoxymethane; beta Catenin; Carcinogens; Colonic Neoplasms; Cyclin D1; eIF-2 Kinase; Enzyme-Linked Immunosorbent Assay; Heptanoic Acids; Immunoenzyme Techniques; Interleukin-4; Male; Naproxen; Nitric Oxide Synthase Type II; Pyrroles; Rats; Rats, Inbred F344; Signal Transduction; Sulindac; Tumor Necrosis Factor-alpha | 2011 |
A chitosan-polypyrrole magnetic nanocomposite as μ-sorbent for isolation of naproxen.
Topics: Adsorption; Chitosan; Magnetite Nanoparticles; Molecular Structure; Naproxen; Particle Size; Polymers; Pyrroles; Solid Phase Extraction; Surface Properties | 2014 |
Electrochemically controlled in-tube solid phase microextraction of naproxen from urine samples using an experimental design.
Topics: Chromatography, High Pressure Liquid; Electrochemical Techniques; Healthy Volunteers; Humans; Limit of Detection; Naproxen; Polymers; Pyrroles; Solid Phase Microextraction | 2015 |
Chondroprotective effect of three different classes of anti-inflammatory agents on human osteoarthritic chondrocytes exposed to IL-1β.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cell Culture Techniques; Cell Survival; Cells, Cultured; Chondrocytes; Cyclooxygenase 2; Dinoprostone; Dose-Response Relationship, Drug; Gene Expression; Humans; Interleukin-1beta; Matrix Metalloproteinases; Middle Aged; Molecular Structure; Naproxen; NF-kappa B; Nitrates; Osteoarthritis, Hip; Pyrroles | 2015 |